DAFNA Capital Management LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2022$2,173,000
+3.6%
160,9830.0%0.57%
+7.2%
Q4 2021$2,098,000
+38.9%
160,9830.0%0.53%
+31.7%
Q3 2021$1,510,000
-8.4%
160,9830.0%0.40%
+16.2%
Q2 2021$1,648,000
-2.1%
160,983
+75.9%
0.34%
-13.8%
Q1 2021$1,684,000
+197.5%
91,531
+453.7%
0.40%
+138.1%
Q4 2020$566,00016,5310.17%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders